How do you know that a biotech bull market is long in the tooth? Every putrid piece of crap that has not already gone public rushes to do so. According to lifescivc.com, we are facing the largest number of simultaneious biotech IPO roadshows ever, even more than in 2000 (a pretty big feat for those of us who remember those days with stacks of reds constantly on our desks and traders asking us what to hold/flip/avoid).
One of them is Nephrogenex (NRX) which on the surface sounds like a legitimate company. They have Phase II data in an extremely large unmet medical need, diabetic nephropathy with a lot of it being statistically significant (at least in subsets). They are...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|